[go: up one dir, main page]

Smith et al., 1945 - Google Patents

The influence of streptomycin and streptothricin on the intestinal flora of mice

Smith et al., 1945

View PDF
Document ID
15823544622166897700
Author
Smith D
Robinson H
Clark D
Publication year
Publication venue
Journal of bacteriology

External Links

Snippet

RESULTS Low-dose therapy. From the data obtained, streptomycin was found to be the most effective of the four drugs in both the rate and the extent of reduction of the numbers of intestinal organisms in the mice (figures 1 and 2). The effectiveness of streptomycin is …
Continue reading at journals.asm.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Micro-organisms
    • Y10S435/822—Micro-organisms using bacteria or actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00—Drug, bio-affecting and body treating compositions
    • Y10S514/867—Diarrhea

Similar Documents

Publication Publication Date Title
Schaedler et al. The fecal flora of various strains of mice. Its bearing on their susceptibility to endotoxin
EP0456418B1 (en) Treatment of clostridium difficile diarrhoea and pseudomembranous colitis
JP5904688B2 (en) Symbiotic lactic acid producing bacteria and use thereof
JP6415430B2 (en) Prophylactic or therapeutic agent for ruminant mastitis
Smith et al. The influence of streptomycin and streptothricin on the intestinal flora of mice
PT986314E (en) Probiotic lactic acid bacterium to treat bacterial infections associated with sids
Dubos et al. The effect of antibacterial drugs on the weight of mice
JPH0656679A (en) Prophylactic and therapeutic composition for clostridium difficile diarrhea and pseudomembranous colitis
JPH0443079B2 (en)
US5455028A (en) Method of inhibiting fungi by Bacillus laterosporus
Hsu et al. Efficacy of enrofloxacin for the treatment of salmonids with bacterial kidney disease, caused by Renibacterium salmoninarum
Price et al. Observations on the in Vivo and in Vitro Development of Bacterial Resistance to Streptomycin
EP0032304B1 (en) Antibiotic compositions
US4223040A (en) Lauric acid for the prevention and treatment of mycobacterial diseases
Frost et al. Antibacterial activity of efrotomycin
EP1894995B1 (en) Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein
WO1995004539A1 (en) Immunopotentiator and method of immunopotentiating animal with the same
Roine et al. The mode of action of aureomycin in the guinea-pig
Iyengar et al. Plumbago zeylanica L.(Chitrak) a gastrointestinal flora normaliser
RU2084234C1 (en) Complex probiotic preparation for veterinary
JP2608301B2 (en) Toxogenic Escherichia coli prophylactic / therapeutic agent
Rodaniche et al. The Action of Tyrothricin on Fecal Streptococci in vitro and in vivo
MILLER Bacterial resistance to antibiotics
El-Sayed et al. Effects of orally administered enrofloxacin on the enteric lactobacillus flora of the chickens
JPH05229954A (en) Therapeutic agent for decrease of leucocyte